Cargando…

Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration

PURPOSE: To monitor retinal pigment epithelial (RPE) atrophy progression during antiangiogenic therapy of neovascular age-related macular degeneration (AMD) over 2 years using polarization-sensitive optical coherence tomography (OCT). DESIGN: Prospective interventional case series. METHODS: setting:...

Descripción completa

Detalles Bibliográficos
Autores principales: Schütze, Christopher, Wedl, Manuela, Baumann, Bernhard, Pircher, Michael, Hitzenberger, Christoph K., Schmidt-Erfurth, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430174/
https://www.ncbi.nlm.nih.gov/pubmed/25769245
http://dx.doi.org/10.1016/j.ajo.2015.02.020
_version_ 1782371141123309568
author Schütze, Christopher
Wedl, Manuela
Baumann, Bernhard
Pircher, Michael
Hitzenberger, Christoph K.
Schmidt-Erfurth, Ursula
author_facet Schütze, Christopher
Wedl, Manuela
Baumann, Bernhard
Pircher, Michael
Hitzenberger, Christoph K.
Schmidt-Erfurth, Ursula
author_sort Schütze, Christopher
collection PubMed
description PURPOSE: To monitor retinal pigment epithelial (RPE) atrophy progression during antiangiogenic therapy of neovascular age-related macular degeneration (AMD) over 2 years using polarization-sensitive optical coherence tomography (OCT). DESIGN: Prospective interventional case series. METHODS: setting: Clinical practice. study population: Thirty patients (31 eyes) with treatment-naïve neovascular AMD. observation procedures: Standard intravitreal therapy (0.5 mg ranibizumab) was administered monthly during the first year and pro re nata (PRN; as-needed) during the second year. Spectral-domain (SD) OCT and polarization-sensitive OCT (selectively imaging the RPE) examinations were performed at baseline and at 1, 3, 6, 12, and 24 months using a standardized protocol. RPE-related changes were evaluated using a semi-automated polarization-sensitive OCT segmentation algorithm and correlated with SD OCT and fundus autofluorescence (FAF) findings. main outcome measures: RPE response, geographic atrophy (GA) progression. RESULTS: Atrophic RPE changes included RPE thinning, RPE porosity, focal RPE atrophy, and development of GA. Early RPE loss (ie, RPE porosity, focal atrophy) increased progressively during initial monthly treatment and remained stable during subsequent PRN-based therapy. GA developed in 61% of eyes at month 24. Mean GA area increased from 0.77 mm(2) at 12 months to 1.10 mm(2) (standard deviation = 1.09 mm(2)) at 24 months. Reactive accumulation of RPE-related material at the lesion borders increased until month 3 and subsequently decreased. CONCLUSIONS: Progressive RPE atrophy and GA developed in the majority of eyes. RPE migration signifies certain RPE plasticity. Polarization-sensitive OCT specifically images RPE-related changes in neovascular AMD, contrary to conventional imaging methods. Polarization-sensitive OCT allows for precisely monitoring the sequence of RPE-related morphologic changes.
format Online
Article
Text
id pubmed-4430174
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-44301742015-06-01 Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration Schütze, Christopher Wedl, Manuela Baumann, Bernhard Pircher, Michael Hitzenberger, Christoph K. Schmidt-Erfurth, Ursula Am J Ophthalmol Original Article PURPOSE: To monitor retinal pigment epithelial (RPE) atrophy progression during antiangiogenic therapy of neovascular age-related macular degeneration (AMD) over 2 years using polarization-sensitive optical coherence tomography (OCT). DESIGN: Prospective interventional case series. METHODS: setting: Clinical practice. study population: Thirty patients (31 eyes) with treatment-naïve neovascular AMD. observation procedures: Standard intravitreal therapy (0.5 mg ranibizumab) was administered monthly during the first year and pro re nata (PRN; as-needed) during the second year. Spectral-domain (SD) OCT and polarization-sensitive OCT (selectively imaging the RPE) examinations were performed at baseline and at 1, 3, 6, 12, and 24 months using a standardized protocol. RPE-related changes were evaluated using a semi-automated polarization-sensitive OCT segmentation algorithm and correlated with SD OCT and fundus autofluorescence (FAF) findings. main outcome measures: RPE response, geographic atrophy (GA) progression. RESULTS: Atrophic RPE changes included RPE thinning, RPE porosity, focal RPE atrophy, and development of GA. Early RPE loss (ie, RPE porosity, focal atrophy) increased progressively during initial monthly treatment and remained stable during subsequent PRN-based therapy. GA developed in 61% of eyes at month 24. Mean GA area increased from 0.77 mm(2) at 12 months to 1.10 mm(2) (standard deviation = 1.09 mm(2)) at 24 months. Reactive accumulation of RPE-related material at the lesion borders increased until month 3 and subsequently decreased. CONCLUSIONS: Progressive RPE atrophy and GA developed in the majority of eyes. RPE migration signifies certain RPE plasticity. Polarization-sensitive OCT specifically images RPE-related changes in neovascular AMD, contrary to conventional imaging methods. Polarization-sensitive OCT allows for precisely monitoring the sequence of RPE-related morphologic changes. Elsevier Science 2015-06 /pmc/articles/PMC4430174/ /pubmed/25769245 http://dx.doi.org/10.1016/j.ajo.2015.02.020 Text en © 2015 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Schütze, Christopher
Wedl, Manuela
Baumann, Bernhard
Pircher, Michael
Hitzenberger, Christoph K.
Schmidt-Erfurth, Ursula
Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
title Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
title_full Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
title_fullStr Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
title_full_unstemmed Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
title_short Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
title_sort progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430174/
https://www.ncbi.nlm.nih.gov/pubmed/25769245
http://dx.doi.org/10.1016/j.ajo.2015.02.020
work_keys_str_mv AT schutzechristopher progressionofretinalpigmentepithelialatrophyinantiangiogenictherapyofneovascularagerelatedmaculardegeneration
AT wedlmanuela progressionofretinalpigmentepithelialatrophyinantiangiogenictherapyofneovascularagerelatedmaculardegeneration
AT baumannbernhard progressionofretinalpigmentepithelialatrophyinantiangiogenictherapyofneovascularagerelatedmaculardegeneration
AT pirchermichael progressionofretinalpigmentepithelialatrophyinantiangiogenictherapyofneovascularagerelatedmaculardegeneration
AT hitzenbergerchristophk progressionofretinalpigmentepithelialatrophyinantiangiogenictherapyofneovascularagerelatedmaculardegeneration
AT schmidterfurthursula progressionofretinalpigmentepithelialatrophyinantiangiogenictherapyofneovascularagerelatedmaculardegeneration